Skip to content
Screener

Total Current Assets at other companies

Gilead Sciences logo
Gilead SciencesGILD
$13.95B-5.3%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$430.09M+16.5%
LQD
Liquidia CorporationLQDA
$333.06M+87.9%
ALN
Alnylam PharmaceuticalsALNY
$4.62B+26.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.24B+78.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$1.84B+62.1%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.45B+144%
Enterprise value$6.2B+151%
P/S10.4×+4.3×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemJune 30,2026December 31,2025
Accounts receivable145,360123,330
Inventory25,76924,887
Prepaid expenses and other current assets26,89018,140
Total current assets636,310549,684
Restricted cash1,7341,482
Long-term investments123,0308,105
Property and equipment, net2,2511,862
Operating lease right-of-use assets12,0248,741

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s total current assets?
Mirum Pharmaceuticals, Inc. (MIRM) reported total current assets of $636.31M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s total current assets changed year-over-year?
Mirum Pharmaceuticals, Inc.'s total current assets increased by 40.3% year-over-year, from $453.4M to $636.31M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total current assets?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s total current assets has grown at a 18.4% compound annual growth rate (CAGR), from $236.35M to $549.68M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Mirum Pharmaceuticals, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude